Orchard Therapeutics plc Quarterly Return On Assets in % from Q3 2019 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Orchard Therapeutics plc quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q3 2023.
  • Orchard Therapeutics plc Return On Assets for the quarter ending September 30, 2023 was -33.5 %, a 48.2% increase year-over-year.
  • Orchard Therapeutics plc annual Return On Assets for 2022 was -60.1 %, a 48.7% decline from 2021.
  • Orchard Therapeutics plc annual Return On Assets for 2021 was -40.4 %, a 17% increase from 2020.
  • Orchard Therapeutics plc annual Return On Assets for 2020 was -48.7 %, a 19.3% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -33.5 +31.2 +48.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -37.8 +16.9 +31% Apr 1, 2023 Jun 30, 2023
Q1 2023 -53.3 -7.21 -15.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -60.1 -19.7 -48.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -64.7 -23.9 -58.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -54.7 -17 -45% Apr 1, 2022 Jun 30, 2022
Q1 2022 -46.1 -3.49 -8.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40.4 +8.3 +17% Oct 1, 2021 Dec 31, 2021
Q3 2021 -40.8 +7.11 +14.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -37.7 +10.9 +22.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -42.6 +2.47 +5.48% Jan 1, 2021 Mar 31, 2021
Q4 2020 -48.7 -7.87 -19.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -47.9 -11.4 -31.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -48.6 Apr 1, 2020 Jun 30, 2020
Q1 2020 -45.1 Jan 1, 2020 Mar 31, 2020
Q4 2019 -40.8 Oct 1, 2019 Dec 31, 2019
Q3 2019 -36.5 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.